Crossmark

Therapeutic evaluation of paclitaxel co-loaded PLGA nanoparticles with imatinib, protamine-imatinib, and gefitinib: comparative in vitro studies in MDA-MB-231 breast cancer cells and in vivo investigations in rats

Crossref DOI link: https://doi.org/10.1007/s00210-025-04460-w

Published Online: 2025-07-18

Published Print: 2026-01

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Laxane, Neha

Yadav, Khushwant S. https://orcid.org/0000-0002-1620-0547
License Information

Text and Data Mining valid from 2025-07-18

Version of Record valid from 2025-07-18
More Information

Article History

Received: 25 February 2025

Accepted: 8 July 2025

First Online: 18 July 2025

Declarations

:

: The author(s) state that they have obtained appropriate institutional board approval. Animal studies were performed in line with the principles of the Committee for the Purpose of Control and Supervision of Experiments on Animals, India. Approval was granted by the Committee for Control and Supervision of Experiments on Animals (CCSEA), Government of India, Ministry of Environment & Forest, New Delhi: Certification for the purpose of “Research” with CCSEA Registration No.: 2105/PO/RcBt/S/20/CPCSEA.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below